To summarize recent developments the role of vitamin D and treatment of vitamin D deficiency in cystic fibrosis.
Although treatment of low vitamin D levels continues to be important for optimizing bone health in cystic fibrosis, increasing data on the extraskeletal effects of vitamin D are becoming available. Exploratory studies of vitamin D in modulation of respiratory and intestinal microbiomes, and the influence of vitamin D on the metabolomic signature of cystic fibrosis, suggest expanded roles for vitamin D in cystic fibrosis disease and treatment.
Emerging developments in cystic fibrosis regarding therapeutics and effects of vitamin D on bone health, inflammation, microbiome, and the metabolome are summarized.
aDepartment of Internal Medicine
bDepartment of Pediatrics, Division of Endocrinology, Diabetes, and Metabolism, Virginia Commonwealth University, Richmond, Virginia, USA
Correspondence to Trang N. Le, MD, Assistant Professor, Departments of Internal Medicine and Pediatrics, Division of Endocrinology, Diabetes, and Metabolism, Virginia Commonwealth University, P.O. Box 980111, Richmond, VA 23298, USA. Tel: +1 804 828 9696; fax: +1 804 828 8389; e-mail: email@example.com